Related by context. All words. (Click for frequent words.) 80 ribavirin RBV 75 alfa 2a 75 anthracycline taxane 73 plus prednisone prednisolone 72 pegylated interferon alpha 72 5 FU leucovorin 71 Peg IFN 71 FUSILEV enhances 70 mitoxantrone plus 70 irinotecan doxorubicin oxaliplatin paclitaxel 70 infliximab monotherapy 70 irinotecan containing 70 plus prednisone 70 lenalidomide Revlimid R 70 docetaxel Taxotere R 70 ACTEMRA TM 70 evaluating picoplatin 70 aflibercept VEGF Trap 70 q8h 70 Budesonide foam crofelemer 69 EGFR expressing mCRC 69 virus HCV protease inhibitor 69 ® lenalidomide 69 FOLFOX6 chemotherapy regimen 69 peg IFN 69 trastuzumab Herceptin R 69 Dementia Related Psychosis 69 cetuximab Erbitux R 69 mapatumumab 69 nilotinib Tasigna ® 69 plus dexamethasone 69 de novo kidney transplant 69 FOLFOX6 69 LymphoStat B belimumab 69 cyclophosphamide chemotherapy 69 pegylated alpha interferon 69 telaprevir dosed 69 Telik logo TELINTRA 68 achieved sustained virologic 68 interferon ribavirin 68 RGT arm 68 docetaxel Taxotere ® 68 estramustine 68 progressive metastatic prostate 68 CIMZIA TM 68 evaluating tivozanib 68 naïve HCV 68 infusional 5-FU/LV 68 dasatinib Sprycel ® 68 vapreotide acetate 68 refractory chronic lymphocytic 68 R sorafenib tablets 68 cyclophosphamide doxorubicin vincristine 68 AAG geldanamycin analog 68 Aptivus ® 68 oral levofloxacin 68 sorafenib tablets 68 oral rivaroxaban 68 baminercept 68 brand ciclesonide HFA 68 Mg Usa 68 relapsed MM 67 PEGINTRON TM 67 PegIFN RBV 67 Xeloda ® 67 maximal tolerated 67 peg interferon 67 5 fluorouracil leucovorin 67 galiximab 67 #mg BID [001] 67 pegylated interferon alpha 2a 67 Known hypersensitivity 67 Peginterferon alfa 2b 67 CHOP chemotherapy 67 plus gemcitabine 67 ® bortezomib 67 adalimumab Humira 67 erlotinib Tarceva ® 67 stage IIIb IV 67 R# #mg BID 67 carcinoma mCRC 67 TO AVOID PREGNANCY WHILE 67 Crofelemer budesonide foam 67 ZOLINZA 67 Mg Uk 67 cyclophosphamide methotrexate 67 idarubicin 67 Pegasys plus Copegus 67 ribavirin therapy 67 PEG interferon 67 monoclonal antibody IgG1 Mab 67 SPRYCEL ® 67 EGFR TKI 67 TAXOTERE ® 66 #mg QD [001] 66 peginterferon alfa 2b 66 patients receiving myelosuppressive 66 plus ribavirin 66 peginterferon 66 Jevtana 66 Tarceva TM 66 midstage clinical 66 Elotuzumab 66 capecitabine Xeloda 66 morphometric vertebral fractures 66 abacavir lamivudine 66 8mg/kg 66 recurrent metastatic ovarian cancer 66 oxaliplatin Eloxatin 66 pegylated interferon alfa 2b 66 sorafenib Nexavar ® 66 #mg QD [002] 66 mg/m2 administered 66 treatment naïve genotype 66 taxane chemotherapy administered 66 Fludara 66 anthracyclines taxanes 66 humanized therapeutic 66 anthracycline containing 66 mcg BID 66 Aflibercept 66 pegylated interferon 66 chemotherapeutic agents carboplatin 66 oral chemotherapeutic agent 66 ELOXATIN 66 Platinol ® cisplatin 66 FEMALES SHOULD BE ADVISED 66 Taxotere ® 66 prednisone CHOP 66 Folfox 66 class mGluR5 inhibitor 66 achieved CCyR 66 HGS ETR1 mapatumumab 66 docetaxel chemotherapy 66 oral ridaforolimus 66 Panzem R NCD 66 sulfonylurea metformin 66 pegylated interferon alfa 2a 66 saline placebo 66 thalidomide Thalomid 66 mcg QD 65 cisplatin gemcitabine 65 detectable HCV RNA 65 FOLFOX4 65 IMiDs ® compound 65 prednisone prednisolone plus 65 acyclovir Lauriad R 65 3mg/kg 65 Xelox 65 PegIFN 65 Pegasys ® 65 refractory NSCLC 65 carboplatin paclitaxel 65 R ribavirin USP 65 dasatinib Sprycel 65 dacarbazine 65 RANK Ligand inhibitor 65 bevacizumab Avastin R 65 achieved ACR# 65 humanised monoclonal antibody 65 paclitaxel Taxol ® 65 antiretroviral naïve 65 ritonavir boosted 65 adjuvant GIST 65 CYT# potent vascular disrupting 65 FOLFOX chemotherapy 65 recurrent glioblastoma multiforme 65 docetaxel Taxotere 65 Gemzar gemcitabine 65 COPEGUS 65 refractory indolent non 65 INTELENCE 65 bortezomib Velcade R 65 Omacetaxine 65 sorafenib Nexavar R 65 dalteparin 65 q#h 65 erlotinib Tarceva R 65 uric acid lowering 65 CK # administered 65 systemic ALCL 65 PREZISTA r 65 infusional 65 IMiDs ® 65 undetectable HCV RNA 65 Aztreonam lysine 65 HCV NS5B polymerase 65 interferon alfa 2b 65 undetectable virus HCV 65 CYP#A# substrate 65 venlafaxine ER 65 peginterferon alpha 2a 65 cytarabine daunorubicin 65 neurologic progression 65 intravesical infusion therapy 65 Pegloticase 65 BARACLUDE R 65 TRIOLEX HE# APOPTONE HE# 65 zolmitriptan 65 bone marrow reticulin deposition 65 Interferon alfa 2b 65 humanized interleukin 6 65 receiving XGEVA 65 metastatic GIST 65 interferon gamma 1b 65 antibody MAb 65 Empatic ™ 65 alpha 2b 65 novel emulsion formulation 65 peginterferon alfa 65 R rilonacept Injection 64 interferon alfa 2a 64 daily Infergen 64 novel VDA molecule 64 COMBIVIR 64 nalbuphine ER 64 Pemetrexed 64 Hypertensive adverse reactions 64 weekly subcutaneous injections 64 YONDELIS 64 aspirin clopidogrel 64 PEG Interferon alfa 64 HCV RESPOND 2 64 memantine HCl 64 Vidaza ® 64 chemotherapy FOLFOX 64 Hormone Refractory Prostate Cancer 64 PROCRIT ® 64 Pruvel TM 64 desvenlafaxine succinate 64 radiation chemoradiation 64 systemic anaplastic large 64 investigational protease inhibitor 64 postoperative chemotherapy 64 CML CP 64 maximally tolerated dose 64 phase IIb study 64 Peginterferon 64 chemotherapy molecularly targeted 64 mg eq 64 ancrod 64 Vitrasert R 64 SinuNase TM 64 doxorubicin cyclophosphamide 64 comparator arm 64 Q#IR 64 alkylating agent 64 vinorelbine tartrate 64 relapsing remitting MS RRMS 64 R lenalidomide 64 Cancer AACR NCI 64 cladribine Cladribine Tablets 64 nicardipine 64 glycoprotein IIb IIIa inhibitor 64 Doxil ® 64 R Bortezomib 64 FOLFOX4 alone 64 serum phosphorous 64 delivers fluocinolone acetonide FA 64 PREZISTA rtv 64 Ixempra 64 gemcitabine Gemzar ® 64 Pegasys peginterferon alfa 2a 64 EPIVIR 64 Submits Biologics License Application 64 R Saizen R 64 pertuzumab 64 alpha 2a 64 raloxifene Evista 64 4mg/kg 64 Copegus ribavirin 64 remission induction 64 PEGylated docetaxel 64 gemcitabine cisplatin 64 naive HCV 64 Initiates Enrollment 64 relapsed refractory multiple myeloma 64 fluorouracil 64 CIMZIA TM certolizumab pegol 64 pamidronate 64 TAXOTERE R 64 Abrupt discontinuation 64 liposomal doxorubicin 64 INSPIRE Trial Phase III 64 peginterferon alfa 2a 64 targeting miR 64 levosimendan 64 MAGE A3 ASCI 64 azilsartan medoxomil 64 receiving chemoradiation therapy 64 anthracycline unless 64 Camptosar ® 64 LEXIVA r 64 AZT zidovudine Retrovir 64 triple nucleoside 64 Meets Primary Endpoint 64 placebo dexamethasone 64 unfractionated heparin UFH 64 imatinib therapy 64 headache nasopharyngitis 64 Cetuximab Erbitux 64 maximally tolerated lipid lowering 64 TNF alpha inhibitor 64 oxymorphone ER 64 mg qd 64 dacarbazine DTIC 64 mycophenolic acid 64 PEGylated anti 64 IIIa inhibitor 64 Pegylated Interferon 64 recombinant PSMA vaccine 64 pegylated interferon alfa 64 gemcitabine Gemzar 64 EDEMA3 trial 64 amoxicillin clavulanate 64 active comparator 64 Chemophase 64 reduce serum phosphate 64 paclitaxel Taxol R 64 statistically significant superiority 64 5 Fluorouracil 64 vitamin B# folic acid 64 chemotherapy cisplatin 64 oral methylnaltrexone 64 gemtuzumab ozogamicin 64 sunitinib Sutent 64 evaluating T DM1 64 DOXIL 64 #mg/day [002] 64 Peg riba 64 Ovitrelle R Serostim 63 indolent follicular non 63 Temsirolimus 63 intravenous iv 63 mg QD 63 NEUPOGEN 63 COPEGUS R 63 motesanib 63 receptor tyrosine kinase inhibitor 63 tumor angiogenesis inhibitors 63 dimebon latrepirdine 63 metastatic hormone refractory 63 APTIVUS r 63 bevacizumab Avastin ® 63 oral deforolimus 63 Amrubicin 63 Naive Patients 63 relapsed myeloma 63 opioid naive 63 Albuferon albinterferon alfa 2b 63 achieve sustained virologic 63 5-FU/LV 63 EGFr expressing metastatic colorectal 63 Peginterferon Alfa 2a 63 antiretroviral naive 63 plus methotrexate 63 plus dacarbazine 63 hypertrichosis occurred 63 chemosensitizer 63 plus COPEGUS 63 somatostatin analog 63 MYLOTARG 63 CorVue ™ 63 clodronate 63 mertansine 63 Golimumab 63 melphalan prednisone 63 LymphoStat B TM 63 Bayer HealthCare Onyx Pharmaceuticals 63 acetonide FA 63 palifermin 63 bezafibrate 63 randomized #:#:# 63 VELCADE melphalan 63 metastatic CRC 63 myocardial infarction ventricular fibrillation 63 Amgen Neulasta ® 63 Ceplene/IL-2 63 TNF inhibitor 63 Sapacitabine 63 evaluating Xcytrin 63 zonisamide SR 63 pharmacologically active isomer 63 pomalidomide 63 REMICADE monotherapy 63 Femara letrozole 63 dexamethasone Decadron 63 adefovir 63 demonstrated antitumor activity 63 gemcitabine carboplatin 63 elotuzumab 63 either acutely decompensated 63 low dose cytarabine 63 PegIntron 63 TDF FTC 63 BRIM2 63 rash pruritus nausea 63 Bosutinib 63 sunitinib malate 63 TELINTRA R 63 non porcine pancreatic 63 Achieves Primary Endpoint 63 pegylated liposomal doxorubicin 63 HGS ETR2 63 patients coinfected 63 NSABP C 63 bortezomib Velcade 63 Velcade bortezomib 63 administered subcutaneously 63 including cyclosporine methotrexate 63 piperacillin tazobactam 63 recurrent metastatic 63 interferon alfa 63 investigational oral hepatitis C 63 Investigational Oral 63 virologically suppressed 63 topical gel formulation 63 agents Tabun Sarin 63 Copegus ® 63 steroid refractory ulcerative 63 pemetrexed Alimta 63 omega interferon 63 Romiplostim 63 Amgen Neulasta R 63 cediranib 63 aflibercept 63 relapsed CLL 63 FOLFIRI 63 Pegintron 63 itraconazole Sporanox 63 VFEND 63 cytotoxic therapy 63 Capesaris 63 standard chemotherapy regimen 63 TORISEL 63 mg q#h 63 refractory AML 63 treatment naive genotype 63 Intravitreal 63 metastatic colorectal carcinoma 63 STELARA ® 63 KRAS mutant tumors 63 BCG refractory carcinoma 63 forodesine 63 cetuximab Erbitux ® 63 INTEGRILIN R 63 NEBIDO VANTAS SUPPRELIN LA 63 metaglidasen 63 Granted Orphan Drug 63 AVASTIN 63 Topotecan 63 TELINTRA 63 fluoropyrimidine oxaliplatin 63 tyrosine kinase inhibitor TKI 63 Navelbine ® 63 IMiDs R 63 Pegylated Liposomal Doxorubicin 63 lintuzumab SGN 63 mg RDEA# 63 refractory CLL 63 ritonavir boosted atazanavir 63 Vidaza azacitidine 63 histamine dihydrochloride 63 Panzem NCD 63 EGFr expressing mCRC 63 kidney urologic 63 Glufosfamide 63 Atripla combines 63 D aspartate NMDA receptor 63 receiving INTRON 63 pharmacogenomic translational research 63 orally inhaled 63 certolizumab 63 SinuNase ™ 63 miconazole Lauriad ® 63 sorafenib Nexavar 63 lenalidomide dexamethasone 63 taxane chemotherapy 63 viral kinetics 63 ARCALYST ® 63 Fulvestrant 63 R pramlintide acetate 63 #mg BID [003] 63 tenofovir emtricitabine 63 Paraplatin ® 63 mg TID 63 chlorambucil 63 AGILECT R 63 concurrent chemoradiation 63 dihydroergotamine mesylate DHE 63 adriamycin 63 plasma kallikrein inhibitor 63 Taxotere chemotherapy 63 Vertex hepatitis C 63 Pegylated interferon 63 TTF Therapy 63 metastatic HRPC 63 nab paclitaxel 63 #mg ATC 62 small molecule Hedgehog 62 Flu Cy 62 Gemzar ® 62 Fludara ® 62 relapsers 62 PEG IFN 62 Infusion reactions 62 MEK Inhibitor 62 Combination REOLYSIN R 62 regorafenib 62 argatroban 62 IMiDs 62 whose tumors overexpress 62 liposomal formulation 62 PEGylated Fab fragment 62 interferon beta 1a infertility 62 trastuzumab Herceptin ® 62 developing Bicifadine serotonin 62 Herceptin trastuzumab 62 adenosine injection 62 approved incretin mimetic 62 GTC recombinant human 62 sustained virologic response 62 Sanvar R 62 Refractory Hodgkin Lymphoma 62 Intravitreal injections 62 paclitaxel carboplatin 62 Noxafil 62 CCyR 62 PEGINTRON REBETOL combination 62 Hsp# Inhibitor 62 biologic antibody 62 xanthine oxidase inhibitor 62 prostate cancer HRPC 62 ribavirin USP 62 DEB# 62 Phase IIb Trial 62 Improved Progression 62 pralatrexate injection folate analogue 62 Desvenlafaxine Succinate 62 via intradermal injections 62 ATRA IV 62 gemcitabine chemotherapy 62 biologic DMARD 62 Triapine R 62 bortezomib refractory 62 paliperidone ER 62 intravenous cyclophosphamide 62 metabolic alkalosis 62 basal bolus regimen 62 3TC lamivudine Epivir 62 vinca alkaloid 62 CYP#A# CYP#D# 62 mg ustekinumab 62 CINQUIL 62 Solid Tumors criteria 62 dose dexamethasone 62 previously untreated follicular 62 Virologic 62 Torisel 62 sunitinib 62 clinically contraindicated 62 By JENNIFER LEARN 62 naloxol derivative 62 fluoropyrimidine 62 CAELYX 62 RoACTEMRA 62 colorectal cancer liver metastases 62 IIa trial 62 cyclophosphamide FC 62 paclitaxel poliglumex 62 catheter occlusion 62 amrubicin 62 pegylated IFN 62 methylnaltrexone bromide 62 STELARA TM 62 oral clodronate 62 docetaxel prednisone 62 CANCIDAS 62 Bezielle 62 ara C 62 TNF Tumor Necrosis Factor 62 metastatic SCCHN 62 intravenous bolus 62 mitoxantrone 62 hormone refractory metastatic prostate 62 INTEGRILIN ® 62 Epratuzumab 62 EGFR tyrosine kinase inhibitor 62 oral prodrug 62 ixabepilone 62 Relapsed Multiple Myeloma 62 nonnucleoside reverse transcriptase inhibitor 62 metastatic castration resistant 62 Demonstrate Significant 62 ATACAND 62 NS5B polymerase 62 Second Pivotal Phase 62 noninferior 62 Crestor rosuvastatin 62 Gleevec imatinib mesylate 62 lipid altering 62 recurrent malignant glioma 62 gefitinib Iressa 62 FDA Approves Novel 62 EOquin TM phase 62 generation purine nucleoside 62 investigational monoclonal antibody 62 Peginterferon alfa 2a 62 tazobactam 62 lispro 62 rimonabant #mg/day 62 mcg kg 62 Temodar ® 62 intra arterial chemotherapy 62 phase Ib 62 TOCOSOL Camptothecin 62 acute peptic ulcer 62 relapsed multiple myeloma 62 CIMZIA ™ 62 sitaxsentan 62 tiuxetan 62 severe hypersensitivity reactions 62 maximal doses 62 DG# compounds targeting 62 HGS# 62 pegnivacogin 62 Launches Generic Version 62 hormone LHRH antagonist 62 zoledronic acid Reclast 62 Tekamlo 62 APTIVUS R 62 PRN FDA Approves 62 Perforomist TM formoterol fumarate 62 methotrexate MTX 62 Ovidrel 62 Sustained virologic response 62 Annamycin 62 GRN# 62 orally inhaled migraine 62 Zorbtive TM 62 chemoradiation therapy 62 mRCC 62 elderly myelodysplastic syndromes 62 dose escalation phase 62 oral vancomycin 62 EGFR expressing metastatic colorectal 62 cilengitide 62 PASI scores 62 Stage IIIB IV 62 iniparib 62 known sulfonamide allergy 62 #mg dose [002] 62 colesevelam HCl 62 GSK# [001] 62 induced macular edema 62 CHOP cyclophosphamide doxorubicin vincristine 62 Seliciclib 62 pyrazinamide 62 Oral Calcitonin 62 refractory indolent NHL 62 null responder HCV 62 Pegasys R 62 imexon 62 Zometa hazard 62 refractory systemic ALCL 62 adjuvant colon cancer 62 metastatic renal cell carcinoma 62 lumiliximab 62 Patients Treated With 62 pegylated interferons 62 MYDICAR ® 62 Ereska 62 divalproex sodium 62 Zevalin R Ibritumomab 62 advanced metastatic renal 62 IMPDH inhibitor 61 CTAP# Capsules 61 Dose Escalation 61 rilonacept 61 FOLFIRI alone 61 EUFLEXXA R 61 epirubicin cisplatin 61 Engerix B 61 administered intranasally 61 clonidine hydrochloride 61 ritonavir boosted lopinavir 61 amprenavir 61 protease inhibitor PI 61 Dacogen injection 61 Alkeran 61 known dihydropyrimidine dehydrogenase 61 High Dose quadruples 61 Ribavirin causes 61 Taxotere docetaxel 61 bupropion SR 61 IV bolus 61 PRT# 61 occlusion PAO 61 Free Survival PFS 61 PEG INTRON R 61 potentially hepatotoxic 61 Alocrest 61 torsemide ER 61 cytidine nucleoside analog 61 LPV r 61 cidofovir 61 NicVAX TM 61 non splenectomized 61 refractory cutaneous T 61 virologic failure 61 XL# anticancer compounds 61 mild vasodilator 61 rolofylline 61 valsartan amlodipine 61 Xcytrin R 61 refractory myeloma 61 thetreatment 61 Renal Impairment 61 Omnitarg 61 oropharyngeal candidiasis OPC 61 adefovir dipivoxil 61 unique alkylating agent 61 sunitinib Sutent ® 61 candesartan cilexetil 61 doxorubicin Adriamycin 61 bendamustine 61 lanthanum carbonate 61 octreotide LAR 61 folinic acid 61 COPEGUS ribavirin 61 Treatment Naïve 61 Deforolimus 61 OMNARIS HFA 61 administered concomitantly 61 pan BCR ABL 61 voriconazole 61 Brentuximab Vedotin SGN 61 VEGFR2 inhibitor 61 4SC AG ISIN DE# 61 Tasigna prolongs 61 Ozarelix 61 Complicated Skin 61 epirubicin cyclophosphamide 61 Sustained Virological Response 61 Aeolus Pharmaceuticals Announces 61 refractory follicular lymphoma 61 tenecteplase 61 injected subcutaneously 61 pan histone deacetylase 61 genotypic resistance 61 unresectable stage 61 metastatic carcinoid 61 achieved PASI 61 Treatment Naive Patients 61 Zemplar Capsules 61 #mg q8h 61 GW# [003] 61 Begins Dosing 61 rapid virologic response 61 inhalations twice 61 metformin HCl 61 metastatic malignant 61 paclitaxel chemotherapy 61 moderate renal impairment 61 HCV SPRINT 61 metformin accumulation 61 olmesartan 61 weekly intravenous infusions 61 Rigel R# 61 trandolapril 61 temsirolimus 61 coronary stent merged 61 Aloprim TM allopurinol sodium 61 Allovectin 7 ® 61 adalimumab 61 metastatic RCC 61 non resectable metastatic 61 paclitaxel Taxol 61 FluCAM 61 HuMax EGFr 61 agalsidase alfa 61 methotrexate therapy 61 Sodium oxybate 61 salmeterol fluticasone 61 alpha interferons 61 FOR FURTHER INFORMATION ABOUT 61 ELACYT 61 octreotide acetate 61 subcutaneously administered 61 Biogen Genentech 61 Albuferon TM 61 Cimzia TM 61 rituximab Rituxan ® 61 etanercept Enbrel 61 evaluating Prochymal 61 thalidomide dexamethasone 61 doxorubicin HCl liposome injection 61 retinal vein occlusion induced 61 budesonide foam 61 Copegus R 61 Epivir 61 CD4 monoclonal antibody 61 Completes Patient Enrollment 61 delayed onset CINV 61 BRINAVESS 61 Dasatinib 61 null responders 61 atovaquone 61 Barr Receives Approval 61 dose dose escalation 61 Degarelix 61 Relapsed Refractory Multiple Myeloma 61 alefacept 61 AEGR 61 mcg albinterferon alfa 2b 61 antirheumatic 61 PEG Intron 61 dacetuzumab 61 VICTRELIS 61 Demonstrates Positive 61 mcg kg REBETOL 61 gastrointestinal mucositis 61 #mg/#mg 61 Tipranavir 61 Adjuvant Treatment 61 sapacitabine CYC# 61 community AABB SmartBrief 61 Talabostat 61 celgosivir 61 Loceryl ® 61 TYKERB 61 atazanavir ritonavir 61 Pertuzumab 61 Pharmacokinetics PK 61 paclitaxel cisplatin 61 daunorubicin 61 saquinavir ritonavir 61 manufactures minimally invasive 61 modified glutathione analog 61 Fondaparinux 61 FOLFOX 61 Cloretazine 61 combining voreloxin 61 Ragweed Allergy 61 MIRAPEX ER 61 amphotericin B 61 Plaque Psoriasis 61 hyperphenylalaninemia HPA due 61 Zalypsis 61 Taxotere R 61 intranasal formulation 61 MVax R 61 Revlimid lenalidomide 61 peginterferon alfa 2a Pegasys 61 PROCTOCORT ® Suppository Hydrocortisone 61 TMP SMX 61 telaprevir pegylated interferon 61 nucleotide analogue 61 metformin sulfonylurea 61 teriflunomide 61 oral mTOR inhibitor 61 non peptidic protease 61 cabazitaxel 61 YOUR LOCAL ANIMAL SHELTER 61 Zenvia ™ 61 PEGylated interferon 61 Phase Ib II 61 Inhaled nitric oxide 61 noninvasive outpatient 61 imatinib Gleevec ® 61 Sprycel dasatinib 61 PNP inhibitor 61 VANTAS ® 61 CG# oncolytic virus 61 irbesartan 61 includes TOLAMBA TM 61 Phase 2b Clinical Trial 61 Sudhir Agrawal D.Phil 61 visilizumab 61 Fast Track Status 61 dexanabinol 61 BARACLUDE ® 61 #I TM# 61 candidates Azedra TM 61 Nexavar sorafenib 61 IONSYS TM 61 mg hydrochlorothiazide 61 REVLIMID ® 61 Epothilone D 61 Newly Diagnosed Multiple Myeloma 61 neratinib 61 zalutumumab 61 Copegus 61 FOLPI 61 ALIMTA cisplatin 61 GPIIb IIIa 61 AKT inhibitor 61 riociguat 61 Cloretazine ® 61 refractory acute myeloid 61 undergoing elective percutaneous 61 Clolar ® 61 #mg #mg #mg [003] 61 AVOREN 61 metastatic malignant melanoma 61 Myelodysplastic Syndrome MDS 61 medically refractory epilepsy 61 verteporfin 61 budesonide pMDI 61 IRX 2 61 pregabalin Lyrica 61 Traficet EN 61 peginterferon ribavirin 60 advanced nonsquamous NSCLC 60 refractory CTCL 60 Melphalan 60 Simulect 60 nadolol 60 Curis collaborator Genentech 60 potent CYP#A# inhibitors 60 BoNTA 60 Nebulized 60 Levoleucovorin 60 esophageal candidiasis 60 vaccines oncolytic virus 60 ug dose 60 particularly SANCTURA XR 60 biochemical relapse 60 tolterodine ER 60 subcutaneous enoxaparin 60 ustekinumab 60 MabCampath 60 orally administered synthetic retinoid 60 radiotherapy RT 60 Anthracycline 60 zileuton injection 60 Lopinavir ritonavir 60 Acute Ischemic Stroke 60 rosuvastatin #mg 60 fludarabine 60 oral nucleoside analogue 60 Initiate Clinical Trial 60 Combivir Kivexa 60 motesanib diphosphate 60 Gemcitabine 60 intradermal injections 60 irinotecan chemotherapy 60 Neulasta ® 60 Viread Emtriva 60 mitomycin 60 valopicitabine 60 complete cytogenetic response 60 mg subcutaneously 60 BENICAR HCT 60 antiangiogenesis therapies 60 metastatic squamous cell carcinoma 60 VIRAMUNE 60 Altera Nebulizer System 60 rALLy clinical trial 60 recurrent NSCLC 60 mitoxantrone chemotherapy 60 metastatic colorectal 60 darunavir r 60 severe oral mucositis 60 NOXAFIL Oral Suspension 60 Median PFS 60 YERVOY 60 pegylated liposomal doxorubicin PLD 60 Gamunex C 60 Rebetol 60 boosted protease inhibitor 60 insulin glulisine 60 hydroxymethyl coenzyme 60 Severe infusion 60 Phase 1b clinical trials 60 tinidazole 60 reversing heparin 60 Fortical ® Unigene nasal 60 Teriflunomide 60 Perifosine KRX 60 tamoxifen Nolvadex ® 60 folate analogue metabolic 60 lopinavir ritonavir Kaletra 60 panitumumab Vectibix 60 PEG Intron ® 60 ceftazidime 60 Kinoid 60 PEGASYS ® 60 dose cytarabine 60 rituximab Rituxan 60 EndoTAGTM 1 60 oblimersen 60 Hepatitis C Antiviral 60 opioid induced constipation OIC 60 vinorelbine 60 Mycophenolate Mofetil 60 CRMD# 60 refractory colorectal cancer 60 5-fluorouracil/leucovorin